Monami Haque
Biographic Data
| ID | 10001057 |
|---|---|
| NAME | Monami Haque |
| GIVEN NAMES | Monami |
| FAMILY NAME | Haque |
| SIGNATURE | HAQUE M |
| AFFILIATIONS | Centre for the Rehabilitation of the Paralysed |
| ORCID | 0000-0002-7970-6094 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia and improve adherence. Their considerably higher costs though have impacted their funding and use. Biosimilars …
Rapid Assessment of Price Instability and Paucity of Medicines and Protection for Covid-19 Across Asia: Findings and Public Health Implications for the Future
Background: Countries have introduced a variety of measures to prevent and treat COVID-19 with medicines and personal protective equipment (PPE), with some countries adopting preventative strategies earlier than others. However, there has been considerable controversy surrounding some treatments. This includes hydroxychloroquine where the initial hype and misinformation lead to shortages, price rises and suicides. Price rises and shortages have a…
No prominent works on this page.
Rapid Assessment of Price Instability and Paucity of Medicines and Protection for Covid-19 Across Asia: Findings and Public Health Implications for the Future
Background: Countries have introduced a variety of measures to prevent and treat COVID-19 with medicines and personal protective equipment (PPE), with some countries adopting preventative strategies earlier than others. However, there has been considerable controversy surrounding some treatments. This includes hydroxychloroquine where the initial hype and misinformation lead to shortages, price rises and suicides. Price rises and shortages have a…
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia and improve adherence. Their considerably higher costs though have impacted their funding and use. Biosimilars …
Business (2 works) · Environmental health (2 works) · Medicine (2 works) · Pharmaceutical Economics and Policy (2 works) · Antibiotic Use and Resistance (1 works) · Biosimilar (1 works) · Biosimilars and Bioanalytical Methods (1 works) · COVID-19 Clinical Research Studies (1 works) · Endocrinology (1 works) · Family medicine (1 works)